Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy.

Gupta, Vineet Govinda; Rangaraju, Ranga Rao; Abbas, Waseem; Bajpai, Peush; Khetrapal, Ruchika

Gupta, Vineet Govinda; Rangaraju, Ranga Rao; Abbas, Waseem; Bajpai, Peush; Khetrapal, Ruchika.

Afiliación

Gupta VG; Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.
Rangaraju RR; Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.
Abbas W; Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.
Bajpai P; Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.
Khetrapal R; Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India.

South Asian J Cancer ; 8(1): 65-68, 2019.

Article en En | MEDLINE | ID: mdl-30766859

Palabras clave

Bladder cancer; head-and-neck cancer; immunotherapy; lung cancer; metastatic cancer; nivolumab; oral cancer; pembrolizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: South Asian J Cancer Año: 2019 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google